A Prospective Observational Multi-institutional Study on Invasive Fungal Infections Following Chemotherapy for Acute Myeloid Leukemia (MISFIC Study): A Real World Scenario from India

George, Biju ; Menon, Hari ; Bhurani, Dinesh ; Damodar, Sharat ; Apte, Shashi ; Seth, Tulika ; Sharma, Ajay ; Shyam, Radhe ; Malhotra, Pankaj ; Easow, Jose ; Lakshmi, Kavitha M. ; Agrawal, Narendra ; Sengar, Manju ; Nataraj, KS ; Ahmed, Rayaz ; Sharma, Sanjeevan ; Khadwal, Alka ; Prakash, Gaurav ; Abraham, Aby ; Devasia, Anup ; Korula, Anu ; Mathews, Vikram (2020) A Prospective Observational Multi-institutional Study on Invasive Fungal Infections Following Chemotherapy for Acute Myeloid Leukemia (MISFIC Study): A Real World Scenario from India Indian Journal of Hematology & Blood Transfusion, 36 (1). pp. 97-103. ISSN 0971-4502

Full text not available from this repository.

Official URL: http://doi.org/10.1007/s12288-019-01173-y

Related URL: http://dx.doi.org/10.1007/s12288-019-01173-y

Abstract

We performed a prospective multi-centre observational study to understand the incidence of IFI in patients with AML in India with use of anti-fungal prophylaxis. All patients with AML receiving either induction chemotherapy or salvage chemotherapy between November 2014 and February 2016 were included in this prospective observational study from 10 Indian centres. IFI was defined as per the revised EORTC-MSG criteria. Data on type of chemotherapy used, type of anti-fungal prophylaxis used, time to neutrophil recovery, incidence of IFI and survival were collected. Two hundred patients (118 male and 82 females) with a median age of 35 years (range: 2-66) were recruited. One hundred and eighty-six (93%) had newly diagnosed acute myeloid leukemia (AML) while 14 (7%) had relapsed disease. IFI occurred in 53 patients (26.5%) with proven or probable IFI occurring in 17 (8.5%). Use of posaconazole prophylaxis (p = 0.027) was the only factor found to be associated with a reduced incidence of IFI. The overall survival (OS) at 6 weeks and 3 months respectively was similar among patients who had IFI (83.0 ± 5.2%; 81.0 ± 5.4%) as compared to those without IFI (84.4 + 3.0%; 81.4 ± 3.2%). This prospective study reveals a high incidence of IFI in patients undergoing chemotherapy for AML in India. The use of posaconazole prophylaxis was associated with a significantly lower incidence of IFI. Optimal strategies to prevent IFI need to be studied.

Item Type:Article
Source:Copyright of this article belongs to Indian Society of Hematology & Blood Transfusion.
ID Code:124110
Deposited On:04 Nov 2021 05:09
Last Modified:04 Nov 2021 05:09

Repository Staff Only: item control page